News & Analysis on Clinical Trial Services & Contract Research And Development
Dutch drug company, Organon, has initiated further studies to develop a specific class of non-hormonal drugs to treat the hot flushes associated with menopause. The new drug, currently in development, is set to be amongst the first of its kind on the...
Belgium genomics company Galapagos has put in place another element in its strategy to develop in-house drug products functions with the appointment of a new chief scientific officer.
German chemical company H&R Wasag was hit once again by the tough market environment in the third quarter of the year, but offset some of the impact by buying up businesses insulated from rises in raw material prices.
Japanese drugmakers Dainippon Pharmaceutical and Sumitomo Pharmaceuticals are to merge in an attempt to increase their standing in international markets and fend off competition at home.
A joint proposal by the UK and Hungarian governments that would allow chemical companies to share the cost of testing to comply with the new REACH legislation has received the support of the European Union's Competitiveness Council.
Pharmaceutical giants GlaxoSmithKline (GSK) has entered into collaboration with InforSense with the aim of establishing a new generation of flexible, informatics platforms that are able to deal with the growing quantities of data in drug discovery...
Inhaled drug delivery company Inyx has reported positive results from a two-year stability study of a non-ozone-depleting, hydrofluoroalkane (HFA) propelled salbutamol metered dose inhaler (MDI) for treating asthma and other respiratory conditions.
Bioreason has launched ClassPharmer Suite Lite, a new edition of the company's software system to increase success in the hits-to-leads-to-clinic process within drug discovery.